UK clinical trial into puberty blockers on hold after medicines regulator steps in
Posted:
A clinical trial into puberty blockers for children has been paused after the medicines regulator warned it should have a minimum age limit of 14 because of the “unquantified risk” of “long-term biological harms”.
Currently more than 50 per cent of women are diagnosed with ovarian cancer at an advanced stage when fewer treatment options are available. A specialist medical tampon could be used to help diagnose ovarian cancer earlier, researchers believe.
Read more here.
A hospital's £9m programme to improve emergency and urgent care will deliver "faster assessments, reduce delays" and offer more efficient treatment for patients, a trust said.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us